Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.56 |
| ▸ | TSHR | P16473 | 3/20 | 0.56 |
| ▸ | TP53 | P04637 | 1/20 | 0.48 |
| ▸ | KDM4C | Q9H3R0 | 2/20 | 0.47 |
| ▸ | KDM4A | O75164 | 1/20 | 0.47 |
| ▸ | PHF8 | Q9UPP1 | 1/20 | 0.47 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.47 |
| ▸ | CA1 | P00915 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | BLM | P54132 | 2/20 | 0.39 |
| ▸ | DEGS1 | O15121 | 1/20 | 0.38 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.36 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.36 |
| ▸ | LTA4H | P09960 | 1/20 | 0.35 |
| ▸ | KDM1A | O60341 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19468469 | 1.00 | ALDH1A1 (0.56) | ALDH1A1TSHRTP53KDM4CKDM4A | |
| SCHEMBL338497 | 1.00 | ALDH1A1 (0.56) | ALDH1A1TSHRTP53KDM4CKDM4A | |
| SCHEMBL19468517 | 1.00 | ALDH1A1 (0.56) | ALDH1A1TSHRTP53KDM4CKDM4A | |
| SCHEMBL19468475 | 1.00 | ALDH1A1 (0.56) | ALDH1A1TSHRTP53KDM4CKDM4A | |
| SCHEMBL19468532 | 1.00 | ALDH1A1 (0.56) | ALDH1A1TSHRTP53KDM4CKDM4A | |
| SCHEMBL19468458 | 1.00 | ALDH1A1 (0.56) | ALDH1A1TSHRTP53KDM4CKDM4A | |
| SCHEMBL5436886 | 1.00 | ALDH1A1 (0.56) | ALDH1A1TSHRTP53KDM4CKDM4A | |
| SCHEMBL19468512 | 1.00 | ALDH1A1 (0.56) | ALDH1A1TSHRTP53KDM4CKDM4A | |
| SCHEMBL15476657 | 1.00 | ALDH1A1 (0.56) | ALDH1A1TSHRTP53KDM4CKDM4A | |
| SCHEMBL19468477 | 1.00 | ALDH1A1 (0.56) | ALDH1A1TSHRTP53KDM4CKDM4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120131462-A | Mild amino acid surfactant and amino acid shampoo | 广州聚容日用品科技有限公司 | 2025-06-13 | — | — | CN | claimed |
| CN-117777987-A | Emulsified acid nanoemulsifier and preparation method and application thereof | 江苏金桥油脂科技有限公司 | 2024-03-29 | — | — | CN | claimed |
| CN-117342966-A | Fatty acyl amino acid triethanolamine salt and preparation method and application thereof | 广州百孚润化工有限公司 | 2024-01-05 | — | — | CN | claimed |
| CN-120131462-A | Mild amino acid surfactant and amino acid shampoo | 广州聚容日用品科技有限公司 | 2025-06-13 | — | — | CN | disclosed |
| CN-120131462-A | Mild amino acid surfactant and amino acid shampoo | 广州聚容日用品科技有限公司 | 2025-06-13 | — | — | CN | disclosed |
| CN-118725150-A | Method for producing dextrin fatty acid ester | 千叶制粉株式会社 | 2024-10-01 | — | — | CN | disclosed |
| CN-117777987-A | Emulsified acid nanoemulsifier and preparation method and application thereof | 江苏金桥油脂科技有限公司 | 2024-03-29 | — | — | CN | disclosed |
| CN-117550996-A | TRPV1 agonist and preparation method thereof | 中国人民解放军军事科学院防化研究院 | 2024-02-13 | — | — | CN | disclosed |
| CN-117342966-A | Fatty acyl amino acid triethanolamine salt and preparation method and application thereof | 广州百孚润化工有限公司 | 2024-01-05 | — | — | CN | disclosed |
| WO-2023184806-A1 | PRODUCTION SYSTEM AND PREPARATION METHOD FOR CONTINUOUS-FLOW PRODUCTION OF SALT-FREE AMINO ACID SURFACTANT | 岳阳科罗德联合化学工业有限公司 | 2023-10-05 | — | — | WO | disclosed |
| CN-115784935-A | Preparation method for synthesizing N-Boc-trans-1, 4-cyclohexanediamine | 泽升科技(广州)有限公司 | 2023-03-14 | — | — | CN | disclosed |
| US-20140051706-A1 | ALPHA HELIX MIMETICS AND METHODS RELATING THERETO | PRISM PHARMA CO., LTD. (JP) | 2014-02-20 | — | — | US | disclosed |
| EP-2678341-A1 | ALPHA HELIX MIMETICS AND METHODS RELATING THERETO | PRISM Pharma Co., Ltd. (JP) | 2014-01-01 | — | — | EP | disclosed |
| WO-2012115286-A1 | ALPHA HELIX MIMETICS AND METHODS RELATING THERETO | PRISM BIOLAB CORPORATION (JP) | 2012-08-30 | — | — | WO | disclosed |
| WO-2008140973-A1 | SEMI-SYNTHETIC GLYCOPEPTIDES WITH ANTIBACTERIAL ACTIVITY | LEAD THERAPEUTICS, INC. (US) | 2008-11-20 | — | — | WO | disclosed |
| US-4579720-A | USING HYDROXYMETHANE DIPHOSPHONIC ACID | PLAINS CHEMICAL DEVELOPMENT CO. (US) | 1986-04-01 | — | — | US | disclosed |
| US-4440646-A | HYDROXY OR HALOALKANEPHOSPHONATES | PLAINS CHEMICAL DEVELOPMENT CO. (US) | 1984-04-03 | — | — | US | disclosed |
| US-4122116-A | HERBICIDES | DEUTSCHE GOLD- UND SILBER- SCHEIDEANSTALT VORMALS ROESSLER (DE) | 1978-10-24 | — | — | US | disclosed |
| US-4108877-A | REACTING ACYL HALIDE WITH COPPER CYANIDE WITH HEATING IN THE PRESENCE OF A CARBOXYLIC ACID NITRILE AND AN ORGANIC SOLVENT | DEUTSCHE GOLD- UND SILBER-SCHEIDEANSTALT VORMALS ROESSLER (DE) | 1978-08-22 | — | — | US | disclosed |
| US-4020091-A | TIN SALTS OF POLYPHOSPHONIC ACIDS | PLAINS CHEMICAL DEVELOPMENT CO. (US) | 1977-04-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140051706-A1 | ALPHA HELIX MIMETICS AND METHODS RELATING THERETO | COL1A1, PLOD3, THPO | ALDH1A1 1615/4885TSHR 3518/4885TP53 77/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.